Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation.
Boots
Johannes M M
JM
Department of Nephrology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands.
van den Ham
E C H
EC
Christiaans
M H L
MH
van Hooff
J P
JP
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D015992:Body Mass Index; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011863:Radioimmunoassay; D012307:Risk Factors; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D000324:Adrenocorticotropic Hormone; D009173:Mycophenolic Acid; D016559:Tacrolimus